Contact
Please use this form to send email to PR contact of this press release:
FDA grants accelerated approval to tovorafenib for patients with relapsed or refractory BRAF-altered pediatric low-grade glioma
TO:
Please use this form to send email to PR contact of this press release:
FDA grants accelerated approval to tovorafenib for patients with relapsed or refractory BRAF-altered pediatric low-grade glioma
TO: